AHNAK has been previously identified as a structural scaffold protein [5], implicated in a range of cancer-related pathways and processed as an ambiguous factor [7,8,11,14,17], which might depend on the type of tumor cells [21]. This evidence concerns the gene PROS1 and neoplasm.